Track B: Research & innovation for the human dimension

Session B.1: Industrial technologies for health perspectives?

Early diagnosis of disease, targeted therapies, regenerative medicine.

Tuesday September 7th, 2010: 11:30 – 13:00

Biomedical applications of nanotechnology can provide significant benefits for patients, for example by allowing earlier detection and diagnosis of diseases and by providing better targeted therapies with fewer side-effects. At the same time, cost savings for the healthcare system are also expected. The European Technology Platform for Nanomedicine plays an important role in identifying these opportunities and stimulating the creation of public-private research consortia. This session will give an overview of the opportunities with examples of the new possibilities offered by nanotechnology. 

Chair

Speakers

AttachmentSize
All Slides - Session B12.86 MB
Slides - Bertrand Loubaton816 KB
Slides - Anders Hogset457.7 KB
Slides - Kevin Shakesheff920.08 KB
Slides - Erno Chiellini1.12 MB

Session B.2: Research & innovation and industrial safety

Tuesday September 7th, 2010: 15:45 – 17:15 

By progressively embedding safety principles into innovation processes and products, industry can contribute to competitiveness while increasing worker safety and public acceptance.

Industrial safety is multi-sectorial by definition: can lessons learnt from research in a specific industrial sector benefit other ones?

What research and innovation is needed to overcome existing occupation health, safety and environmental issues including those related to new technologies ? 

Chair

Speakers

  • H. Wenzel, Vienna Consulting Engineers (Austria)
  • Knut Øien, Senior Scientist at SINTEF Safety and Reliability, Trondheim (Norway)
  • Emmanuelle Brun, European Agency for Safety and Health at Work – EU-OSHA (EU) on ‘Making Europe a safer, healthier, and more productive place to work’
AttachmentSize
All Slides - B23.47 MB
Slides - Richard Gowland184.64 KB
Slides - H Wenzel2.04 MB
Slides - Knut Oien832.66 KB
Slides - Emmannuelle Brun950.52 KB

Session B.3: Research & innovation and consumer safety

Tuesday September 7th, 2010: 17:45 – 19:15

How does research eliminate hazards for consumers when introducing, for instance, nanoparticles and new innovative materials into products?

What can be done to increase the acceptability of such materials to consumers?

Chair

Speakers

  • Iseult Lynch, University College Dublin (Ireland)
  • Hermann Stamm, Head of Nanotechnology and Molecular Imaging Unit (NMI) at the Institute for Health and Consumer Protection (IHCP) of the European Commission's Joint Research Centre (JRC) (Italy)
  • Dirk Vangeneugden, Project and Business Development Manager, VITO (Belgium)
AttachmentSize
All Slides - Session B34.03 MB
Slides - Anne Gergely358.87 KB
Slides - Iseult Lynch1.03 MB
Slides - Hermann Stamm1.4 MB
Slides - Dirk Vangeneugden2.09 MB

Session B.4: Research & innovation and a worker-friendly production environment

Wednesday September 8th, 2010: 11:30 – 13:00

In future production environments, routine, tiring, hazardous and/or unpleasant operations will increasingly be handled by robots and machines. Advances in ergonomy, human-robot interactions, user interfaces and safe remote operations are key factors. 

What are the remaining challenges to ensure clean, safe, healthy and comfortable working conditions ?  

Chair

Speakers

  • Erik Pekkeriet, Universiteit Wageningen (The Netherlands)
  • Ute Seeling, Director German research institute KWF (Germany)
  • Ulrika Harlin, Swerea (Sweden) on 'Industrial work of the future for increased competitiveness
  • Per Gullander, Researcher Project Manager, Swerea IVF (Sweden)
AttachmentSize
All Slides - Session B44.73 MB
Slides - Koorosh Khodabandehloo1.53 MB
Slides - Erik Pekkeriet875.14 KB
Slides - Ute Seeling1.22 MB
Slides - Ulrika Harlin827.83 KB